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ABSTRACT
Background: The body of literature considering caffeine as an ergogenic aid
has primarily considered typically aerobic based exercise, male participants and
moderate-to large-caffeine doses. With this in mind the aim of this project was to
explore the effects of a low-caffeine dose upon maximal voluntary contraction
(MVC) and muscular endurance (time to task failure, TTF) at heavier-and
lighter-loads.
Methods: Nineteen physically active, habitual caffeine consuming females randomly
performed four testing conditions; two with a low-dose of caffeine (100 mg equating
to mean = 1.5 ± 0.18 mg·kg−1) and two placebo conditions, where they performed
a maximal strength test (MVC) knee extension at 45 followed by a task of
relative muscular endurance (sustained isometric contraction for TTF) using either
heavier-(70% MVC) and lighter-(30% MVC) loads. Each participant performed
each load condition following both caffeine and placebo consumption. Immediately
following cessation of the muscular endurance test participants were asked to
report their rating of perceived effort (RPE) and rating of perceived discomfort
(RPD).
Results: Analyses revealed a significant effect for caffeine upon MVC compared
to placebo (p = 0.007). We also found a significantly greater TTF for the
lighter-compared to the heavier-load condition (p < 0.0001); however, there was
no significant effect comparing caffeine to placebo (p = 0.2368), but insufficient
precision of estimates to infer equivalence in either lighter-(p = 0.750) or heavier-load
(p = 0.262) conditions. There were no statistically significant effects for caffeine
compared with placebo, or lighter-compared with heavier-loads, for RPE and RPD
(all p > 0.05). RPE was statistically equivalent between caffeine and placebo for
both lighter-(p = 0.007) and heavier-load (p = 0.002) conditions and RPD for
heavier-(p = 0.006) but not lighter-load (p = 0.136).
Discussion: This is the first study to demonstrate a positive effect on strength from a
low caffeine dose in female participants. However, it is unclear whether caffeine
positively impacts upon relative muscular endurance in either heavier-or lighter-
loads. Further, both RPE and RPD appear to be relatively similar during isometric
tasks performed to task failure independently of caffeine supplementation or load.
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These findings may have implications for persons wishing to avoid side-effects or
withdrawal symptoms associated with larger caffeine doses whilst still attaining the
positive strength responses.
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INTRODUCTION
Caffeine is evidenced to increase productivity, improve concentration and reduce fatigue
(Bazzucchi et al., 2011; Pickering & Kiely, 2018) and as such, in an effort to enhance
performance, it is reported that ~74% of athletes consume caffeine as an ergogenic aid
prior to competition (Del Coso, Muñoz & Muñoz-Guerra, 2011). Historically the body of
research has considered the effects of caffeine upon predominantly aerobic endurance
type exercise, for example time to exhaustion in well-trained and elite cyclists (Costill,
Dalsky & Fink, 1978; Pasman et al., 1995), 2,000 m rowing performance (Bruce et al., 2000)
and 1,500 m treadmill running (Wiles et al., 1992). Indeed, a recent umbrella review of
published meta-analyses considering the effects of caffeine supplementation on a range of
performance outcomes found that evidence was stronger for predominantly aerobic vs.
anaerobic tasks (Grgic et al., 2019a). Yet, perhaps in part due to the popularity of
caffeinated supplements aimed to harness its aforementioned benefits, caffeine is
commonly consumed as part of a ‘pre-workout’ with the desire to enhance strength, power
and muscular endurance before partaking in resistance exercise or strength/power-based
tasks (Cesareo et al., 2019). In comparison with aerobic endurance tasks, there is still a
gap within the present body of literature considering caffeine consumption and muscular
strength/endurance tasks. Further, as with most resistance training studies, the body of
research considering the maximal strength and muscular endurance effects of caffeine have
dominantly considered trained or untrained male participants.
Indeed, a recommendation from recent reviews by Grgic et al. (2019a, 2019b) was
for more research to be conducted in women. This is supported by evidence suggesting
sex-differences in subjective and physiological responses to caffeine consumption
(Temple & Ziegler, 2011). To date research considering female participants has used large
caffeine doses. For example Goldstein et al. (2010) considered 15 females, reporting a small
yet significantly (p < 0.05) greater barbell bench press 1RM for caffeine (6 mg·kg−1)
compared to placebo conditions (52.9 ± 11.1 kg vs. 52.1 ± 11.7 kg, respectively);
and Sabblah, Dixon & Bottoms (2015), who compared caffeine (5 mg·kg−1) and placebo for
strength differences between males (n = 10) and females (n = 8). The authors
reported significantly greater 1RM bench press following caffeine compared to placebo,
(p = 0.016; males = 101.5 ± 28.9 to 107.5 ± 30.5 kg, females = 32.2 ± 9.0 to 35.3 ± 7.3 kg)
with no between sex differences. In addition, they reported a tendency for an increase in
relative muscular endurance (repetitions at 40% 1RM; p = 0.059) with a between sex
difference of p = 0.061 in favour of males compared to females as a result of caffeine
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ingestion. Finally, Sabblah, Dixon & Bottoms (2015) found no improvement in squat 1RM
for either males or females for the caffeine condition. The lack of research considering
female participants might simply be a reflection that the bulk of strength training research
considers male participants. However, it might also be a product of the sensitivity around
female menstrual cycles and oral contraceptive use which might impact the effects of
caffeine upon the body (Abernethy & Todd, 1985).
A further limitation of present literature is a lack of investigation into low caffeine
dosage (<3 mg·kg−1) for strength measures (Spriet, 2014). Indeed, Grgic et al. (2019a) note
that the doses of caffeine across the body of literature have generally been around 6 mg of
caffeine per kilogram of body mass (mg·kg−1) or greater. Some studies suggest that
lower doses of caffeine could be impactful upon strength performance. For example, Arazi,
Hoseinihaji & Eghbali (2016) reported maximal strength (leg press 1RM) across two
caffeine conditions (2 mg·kg−1 and 5 mg·kg−1) as well as a placebo condition. Whilst
the analyses didn’t reveal a statistically significant difference, their descriptive data
(leg press 1RM; placebo = 154 ± 27.3 kg vs. 2 mg·kg−1 of caffeine = 171 ± 15.9 kg) seems
noteworthy. A more recent study of the dose-response effects of 2 mg·kg−1, 4 mg·kg−1 and
6 mg·kg−1 of caffeine upon both upper and lower body strength and relative muscular
endurance in males reported a linear trend for upper body strength, but no clear
dose-response relationship for lower body strength or relative muscular endurance
(Grgic et al., 2020). Thus, there is the possibility that low doses of caffeine may still produce
performance enhancing effects. This might be particularly important considering studies
reporting negative side effects to caffeine supplementation. For instance, Goldstein et al.
(2010) reported that 20% of participants ‘exhibited intense emotional side effects,
including an expressed inability to verbally communicate, focus, and/or remain still as well
as the feeling of wanting to cry’ (page 4). Other studies have negative side-effects following
caffeine withdrawal, including severe fatigue, increased muscle pain and cramps, sleep
disturbance, irritability, headaches, and occasional nausea (Nehlig, 1999; Juliano &
Griffiths, 2004). In review, withdrawal symptoms were evident from a median dose of
357 mg (in a 60 kg female and 80 kg male this equates to 5.95 mg·kg−1 and 4.46 mg·kg−1,
respectively) but also in doses as low as 129 mg (in the same example: 2.15 mg·kg−1 and
1.61 mg·kg−1, respectively; Strain et al., 1994).
Finally, an additional gap within the body of research is that to date no empirical
publications have considered the impacts of caffeine supplementation upon the effects
of heavier-compared with lighter-load muscular endurance tasks. These might differ
following caffeine consumption as a result of the effects of caffeine on the neurological
system and the potentiation of force production during submaximal intensities
(Tarnopolsky, 2008), as well as the potentially differing effects of caffeine on slow twitch
muscle fibres (Davis & Green, 2009). Current research suggests that lighter-load resistance
exercise tasks, whilst producing similar perceptions of effort at momentary task failure,
produce greater discomfort compared to heavier loads (e.g. Fisher & Steele, 2017;
Stuart et al., 2018). However, these studies did not consider the use of caffeine ingestion
which might improve endurance performance through a reduction in perceived effort at
submaximal exercise intensities thus deterring task disengagement due to maximal
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perceived effort for longer (Duncan et al., 2013; De Morree, Klein & Marcora, 2014;
Smirnaul et al., 2017). It has also been shown that caffeine produces analgesic effects and
thus may improve performance similarly by reducing pain perception allowing higher
exercise intensities to be produced at the same level of pain perception, or again deterring
task disengagement due to reaching maximum tolerable pain levels (Motl, O’Connor &
Dishman, 2003;Motl et al., 2006; Astorino et al., 2011; Duncan et al., 2013). Indeed, relative
muscular endurance typically does not change with interventions including resistance
training, but where it does it has been speculated this may be due to reductions in
perceived discomfort (Fisher et al., 2020). However, both the perceived effort and perceived
pain reducing effects of caffeine have only been shown with higher doses (4–10 mg·kg−1).
With the above in mind, the aim of this study was to consider the effects of a low
caffeine dose (100 mg/<2 mg·kg−1) compared to a placebo upon maximal strength and
relative muscular endurance tasks, in addition to perceptions of effort and discomfort, at
both heavier-and lighter-loads (70% and 30% MVC, respectively) in a female population.
In this study design we have utilised isometric knee extension strength testing, and
time to task failure (TTF) at %MVC. We hypothesised that caffeine would positively
impact MVC, as well as TTF at 30% MVC and be related to the perceptual effects of
caffeine.
METHODS
Experimental approach to the problem
The present study used a double-blind, randomised control and crossover counterbalanced
research design whereby all participants completed caffeine and placebo conditions for
maximal strength testing (MVC) of the knee extensors and both heavier-(70% MVC) and
lighter-(30% MVC) load isometric knee extension TTF (e.g. all participants performed
four conditions).
Participants
Following approval from Solent University Health, Exercise and Sport Science ethics
committee (ethical application reference number: wallg2018), 19 physically active
female participants (age range 18–35 years, mean (±SD) age = 21.6 ± 3.8 years, height =
1.68 ± 0.07 cm, mass = 67.9 ± 8.4 kg, body mass index = 24.2 ± 2.8) were recruited from a
University campus. All participants were considered healthy based upon responses to a
modified physical activity readiness questionnaire. Inclusion criteria required that all
participants be habitual caffeine drinkers (>100 mg/day and recorded via a 4-day food
diary based onMotl et al., 2006) and be free frommusculoskeletal injuries for which a knee
extension task might be contraindicated, as well as not currently undertaking a structured
resistance training programme. All participants were provided a verbal briefing about
the study, provided a participant information sheet for their records, and completed an
informed consent form. Exclusion criteria included being pregnant, breast feeding
(<6 months), consuming androgenic anabolic steroids, diabetic, hypertensive, consuming
>300 mg/day of caffeine.
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Familiarisation
Prior to testing, each participant attended the laboratory where height and mass were
recorded, and paperwork were completed. The isokinetic dynamometer (Humac Norm,
CSMi, Stoughton, MA, USA) was set up to ensure participant comfort, whilst the lateral
epicondyle of the right knee was aligned with the axis of rotation on the device.
The cushioning pad of the leg extension was positioned central to the shin and seat
and position measurements were recorded for replication for each condition for each
participant. All participants confirmed right leg dominance when asked with which leg
they would kick a football with and thus, the right leg was used for testing for all
conditions. Following set-up each participant completed MVC testing at 45 of knee
extension and the lighter load (30% MVC) condition as outlined below (data was not
recorded) to provide familiarisation to isokinetic testing and isometric TTF. During the
familiarisation session participants were also informed of the use of rating of perceived
exertion-effort and rating of perceived exertion and perceived discomfort scales (Steele
et al., 2017). The scales and instructions are available on the Open Science Framework
(https://osf.io/ufvy8/).
Blinding, randomisation and dosage
A person external to the project was asked to label both the caffeine and placebo tablet as
supplement ‘A’ or ‘B’ and deposit each into an opaque container to ensure double blinding
from both the researchers providing the supplement and the participants. The caffeine
consisted of 2 × Pro-Plus Tablets (a total of 100 mg caffeine), and the placebo was 2 × Deva
Vegan D2 Vitamin D 1200IU tablet (0.06 mg D2). Vitamin D2 was selected based on
similarity and size to the caffeine tablet and since studies have shown this to be ineffective
upon muscular strength (Chiang et al., 2017). For the caffeine conditions the dosage of
caffeine was maintained at 100 mg per person since this represents ecological validity for
consumption (e.g. we believe a person is likely to consume the dosage suggested on the
packet not calculate a specific dosage based on their body mass). The dosage provided
resulted in a body mass relative dose at 1.50 ± 0.18 mg·kg−1 (range = 1.1 to 1.85 mg·kg−1).1
Testing
On the morning of testing, participants had been instructed not to consume caffeine-
containing food or beverages. A sheet including drinks, food and medication to avoid was
provided in advance to participants (in brief this included; coffee, tea, chocolate,
carbonated beverages, energy drinks of any kind, caffeine/energy gels, chewing gum,
supplement bars including protein and energy bars, weight-loss tablets, pain-relieving
tablets including codeine, paracetamol, ibuprofen, etc. and alcohol). Participants
confirmed they had not participated in strenuous exercise for 48-h prior to testing for each
condition. Participants were not requested to attend the testing sessions in a fasted
state but were asked to replicate any foods consumed prior to the first testing condition for
the latter conditions. Participants attended the laboratory for testing between 8 am and
11 am, and testing time was standardized for each participant across all conditions.
1 For context and comparison, an 8.4fl.oz/
250 ml can of Red Bull contains 80 mg of
caffeine, equal to 1.17 mg·kg−1 for the
present participants.
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Participants returned no less than 6 days following the familiarisation for the first
testing session to eliminate the effects of any delayed onset muscle soreness. Each
participant received either supplement ‘A’ or ‘B’ (selected at random via a random
letter generator) and was asked to consume it together with 150 ml of tap water (Smit &
Rogers, 2000). After 60 min, during which no food consumption or physical activity
was permitted, and toilet breaks and water consumption were logged, the participant was
asked to complete a brief 5-min warm-up on a cycle ergometer (Monark, Ergomedic 874e)
up to 60% age-predicted maximum heart rate to warm key muscles (Fisher & Steele,
2017). Following this, the participant completed a maximal voluntary contraction (MVC)
at 45 knee extension. Participants were instructed to gradually build up to a maximal
effort over 3 s and were instructed to gradually reduce their effort once it was clear that a
max torque had been achieved (i.e. when the torque reading was no longer increasing).
After 30 s rest, the participant completed the isometric leg extension task to failure.
The lever arm was maintained at 45 knee extension and the participant was provided
visual feedback on a display screen of what force to maintain (70% or 30% for heavier-and
lighter-load conditions, respectively) with an upper and lower bar of ±5% (e.g. if MVC
was 100 Nm then for the 70% condition a bar was shown at 70 Nm with an upper and
lower bar 3.5 Nm above and below, respectively). Verbal encouragement was provided
throughout to ensure maximal exerted effort (Timmins & Saunders, 2014), and if they fell
below the bottom torque limit then they were encouraged to attempt to regain their set
torque output. The task was ceased when the participant could not maintain the required
force despite attempting to with maximal effort. Rating of perceived effort (RPE) and
rating of perceived discomfort (RPD) was measured and recorded immediately following
the isometric knee extension task (Steele et al., 2017) along with TTF (seconds).
For the successive three testing sessions with no less than 6 days recovery between,
participants repeated the testing process as described above. Each participant was
randomly assigned a supplement and condition from their remaining allocation, for
example each participant had 2 × ‘A’ and 2 × ‘B’ supplements, for both heavier-and lighter-
load conditions (70% and 30% MVC, respectively).
Statistical analysis
The independent variables were the training load (70% and 30% MVC) and the
supplement condition (placebo and caffeine). The dependent variables included MVC,
TTF, RPE and RPD. All analysis was done using the ‘lme4’ package (Bates et al., 2015) and
‘lmerTest’ in R (v3.6.1; R Foundation for Statistical Computing, Vienna, Austria. URL
http://www.R-project.org/). Linear mixed modelling was used to analyse all outcomes
using Restricted Maximum Likelihood estimation with participants as a level 3 variable,
‘Load’ (70% and 30% MVC) as a level 2 variable, and ‘Condition’ (placebo and caffeine) as
a level 1 variable. ‘Load’ and ‘Condition’ were modelled as fixed factors with random
intercepts by participants included. For MVC only Condition as examined as a factor with
four separate observations per participant and two per condition due to this outcome
being measured at the beginning of every trial. Estimated marginal means with 95%
confidence intervals were produced using the ‘emmeans’ package from each model
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(for each Condition for MVC, and for each Condition by Load for all other dependent
variables) in addition to pairwise contrasts. Contrasts were also performed with an
equivalence testing approach and 90% confidence intervals. Equivalence bands were
determined from reliability data for MVC taken from our laboratory using the same set-up
as in the present study. The half-width of the minimal detectable change % (6.98%) was
used. Because we did not have similar reliability data for TTF we opted to use the same
relative minimal detectable change value for this dependent variable also in setting
equivalence bands. The absolute equivalence bands for MVC and TTF were ±6.45 Nm
and ±14.25 s respectively. For RPE and RPD we used the half-width of the minimal
detectable change determined from previously published reliability data for these scales
(Steele et al., 2017). The absolute equivalence bands for RPE and RPS were ±1.18 and ±1.40
respectively. All tests were conducted with a = 0.05 for determination of statistical
significance. In addition, data visualisation included plotting individual raw data and
estimated marginal means for repeated measures between condition, in addition to
pairwise contrasts with both 95% and 90% confidence intervals and equivalence bands.
Standardised effect sizes were calculated as Cohen’s d (Cohen, 1992), and interpreted using
Cohen’s thresholds (>0.2 to <0.5 ‘small’; >0.5 to <0.8 ‘moderate’; >0.8 ‘large’) using the
eff_size() function in the emmeans package.
RESULTS
Maximal voluntary contraction
A statistically significant main effect of Condition was found in the linear mixed model for
MVC (F(1, 56) = 7.906, p = 0.007) with a higher MVC for caffeine (caffeine = 92.8 Nm
(78.5 to 107.0 Nm), placebo = 82.6 Nm (68.4 to 96.8 Nm)). Cohen’s d for the between
condition contrast was 0.65 (0.15 to 1.14). Equivalence testing did not reveal a statistically
significant effect (t(56) = −1.141, p = 0.129) for the pairwise contrast. Visual inspection
of Fig. 1 reveals that traditional hypothesis testing excludes a null hypothesis of 0 Nm
difference between caffeine and placebo with a greater MVC seen for caffeine. However,
the 95% confidence intervals do not exclude the upper limit of the equivalence bands and
so it is unclear whether there is a meaningful effect of caffeine upon MVC.
Time to task failure
There was no statistically significant main effect of Condition found in the linear mixed
model for TTF (F(1, 54) = 1.431, p = 0.2368) though there was a significant main effect
of Load (F(1, 54) = 1.431, p < 0.001) with greater TTF for 30% MVC (caffeine(30%
MVC) = 204.1 s (172.1 to 236.1 s), placebo(30%MVC) = 178.2 s (146.2 to 210.2 s), caffeine
(70% MVC) = 65.3 s (33.3 to 97.3 s), placebo(70% MVC) = 62.1 s (30.0 to 94.1 s)).
There was also no statistically significant interaction effect of Condition × Load
(F(1, 54) = 0.870, p = 0.355). Cohen’s d for the between condition contrast was 0.49
(−0.17 to 1.15) in 30% MVC and 0.06 (−0.59 to 0.71) in 70% MVC. Equivalence testing
also did not reveal a statistically significant effect for Condition either in 30% MVC
(t(54) = 0.679, p = 0.750) or 70% MVC (t(54) = −0.640, p = 0.262) for the pairwise contrasts.
Visual inspection of Fig. 2 reveals that traditional hypothesis testing fails to exclude a null
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hypothesis of 0 Nm difference between caffeine and placebo, yet the interval estimates are
insufficiently precise to infer equivalence between the conditions.
Rating of perceived effort
There was no statistically significant main effect of Condition found in the linear mixed
model for RPE (F(1, 54) = 0.518, p = 0.475) or of Load (F(1, 54) = 3.056, p = 0.086), and
no statistically significant interaction effort of Condition × Load (F(1, 54) = 0.095, p = 0.759)
with RPE appearing similar across all trials (caffeine(30% MVC) = 8.26 (7.65 to 8.87),
placebo (30% MVC) = 8.00 (7.39 to 8.61), caffeine(70% MVC) = 8.63 (8.02 to 8.24),
placebo(70% MVC) = 8.53 (7.92 to 9.14)). Cohen’s d for the between condition contrast
was 0.24 (−0.42 to 0.89) in 30% MVC and 0.09 (−0.56 to 0.74) in 70% MVC. Equivalence
testing revealed a statistically significant effect for Condition in both 30% MVC
(t(54) = −2.528, p = 0.007) and 70% MVC (t(54) = −2.964, p = 0.002) for the pairwise
contrasts. Visual inspection of Fig. 3 reveals that across both 30% MVC and 70% MVC
there was equivalence in RPE between caffeine and placebo.
Rating of perceived discomfort
There was no statistically significant main effect of Condition found in the linear mixed
model for RPE (F(1, 54) = 1.772, p = 0.189) or of Load (F(1, 54) = 0.088, p = 0.769), and
no statistically significant interaction effort of Condition × Load (F(1, 54) = 1.072, p = 0.305)
with RPD appearing similar across all trials (caffeine(30% MVC) = 8.00 (7.26 to 8.74),
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placebo (30% MVC) = 7.16 (6.42 to 7.89), caffeine (70% MVC) = 7.53 (6.79 to 8.26),
placebo (70% MVC) = 7.42 (6.69 to 8.16)). Cohen’s d for the between condition
contrast was 0.54 (−0.11 to 1.20) in 30% MVC, and 0.07 (−0.58 to 0.72) in 70% MVC.
Equivalence testing revealed a statistically significant effect for Condition in the 70%MVC
(t(54) = −2.572, p = 0.006) but not 30% MVC (t(54) = −1.108, p = 0.136) for the pairwise
contrasts. Visual inspection of Fig. 4 reveals that for 70% MVC there was equivalence
in RPD between caffeine and placebo.
DISCUSSION
The present study considered the effects of low doses of caffeine upon maximal force
(MVC) and TTF at 30% and 70% MVC in females. The aim of the study was to better
understand whether low caffeine doses can impact maximal strength (MVC) performance
as well as affect relative muscular endurance (TTF) and whether this was associated
with an effect of reducing perceptions of effort or discomfort. To our knowledge this is the
first study to consider the impact of low doses of caffeine (<2 mg·kg−1) upon MVC and
TTF for heavier-and lighter-loads in females. We believe our study represents an
ecologically valid approach since people typically consume a predetermined absolute
dosage of caffeine (e.g. 2 × Pro-Plus tablets; equating to a total of 100 mg caffeine) and
rarely calculate a specific dosage based on their body mass. Our main findings were
that 100mg caffeine (~1.5 mg·kg−1) supported an increase in strength, but not relative
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Figure 2 Time to task failure (A) and difference in time to task failure (B) for lighter (30%MVC) and
heavier (70% MVC) load and between caffeine and placebo conditions.
Full-size DOI: 10.7717/peerj.9144/fig-2
Waller et al. (2020), PeerJ, DOI 10.7717/peerj.9144 9/18
muscular endurance compared to a placebo condition. These results are discussed in
greater detail below.
Maximal voluntary contraction
Our analyses revealed a significant effect for caffeine upon MVC in line with previous
research showing positive effects upon strength as a result of caffeine ingestion (Grgic et al.,
2020). Thus, even at low doses caffeine may have the potential to positively impact
maximal force production. However, whilst analyses did reveal a statistically significant
effect (i.e. excluding a zero effect), the confidence intervals did not exclude the upper
equivalence bands (Fig. 1B) and therefore it is unclear how meaningful this increase in
MVC is. However, the standardised effect size (Cohen’s d) for the caffeine compared to
placebo condition for MVC was moderate (d = 0.645 (0.155 to 1.14)) which interestingly
is larger than that reported in meta-analyses considered in a recent umbrella review
(Grgic et al., 2019a). Though, the inclusion of the upper equivalence band and the
point and interval estimates of prior meta-analyses in the confidence interval range for
our estimate suggests that the true population effect may be lower and questions its
meaningfulness. Further, prior research examining maximal strength in females has shown
generally trivial to small effects at best (Goldstein et al., 2010; Sabblah, Dixon & Bottoms,
2015). However, we should recognize that caffeine consumption in females might
stimulate very individual responses to MVC based on both genetic factors and the use of an
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Figure 3 Rating of perceived effort (A) and difference in rating of perceived effort (B) for lighter
(30% MVC) and heavier (70% MVC) load and between caffeine and placebo conditions.
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oral contraceptive pill (Guest et al., 2018; Abernethy & Todd, 1985). Inspection of the
individual participant data in Fig. 1 suggests there was considerable inter-individual
variation. However, the extent to which this is true inter-individual variation in response to
caffeine as opposed to merely test-retest variation is unclear and future research should
consider employing replicated randomised cross-over designs to investigate this
(Atkinson, Williamson & Batterham, 2019).
Time to task failure
As expected, and supported by previous research, there was a statistically significantly
longer TTF for the 30% MVC conditions compared to the 70% MVC conditions (30%
MVC: caffeine = 204.1 s, placebo = 178.2 s; 70% MVC: caffeine = 65.3 s, placebo = 62.1 s).
The body of literature has reported that when exercising with lighter loads a person
can/must exercise for considerably longer to reach momentary failure (Fisher & Steele,
2017; Stuart et al., 2018). In contrast to previous research, our analyses revealed no
statistically significant difference for TTF as result of caffeine compared to placebo
ingestion. Grgic et al. (2020) recently reported significant increases in relative muscular
endurance at 60% 1RM at all doses examined, though this study was in males only.
Sabblah, Dixon & Bottoms (2015) found that, though not significant, any effect on relative
muscular endurance at 40% 1RM appeared to be larger in males compared with females.
It is worth considering however that with increases in strength resultant from
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Figure 4 Rating of perceived discomfort (A) and difference in rating of perceived discomfort (B) for
lighter (30% MVC) and heavier (70% MVC) load and between caffeine and placebo conditions.
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interventions such as resistance training, relative muscular endurance typically does not
change (Fisher et al., 2020). In previous studies, strength is normally measured using
1RM on a separate day to the placebo and caffeine conditions and so where there are
changes this may be due to increased strength from supplementation resulting in the load
used for muscular endurance testing being relatively less. In the present study we tested
MVC on the day of each condition and after supplementation. Thus, the lack of
change in relative muscular endurance may be due to the fact that, though strength (MVC)
increased, the load used for muscular endurance testing was set relative to that MVC.
However, while there was no statistically significant effect for Condition, or Condition ×
Load interaction, descriptively the lighter load (30% MVC) condition appears to
differ between caffeine and placebo conditions (204.1 ± 97.32 s and 160.95 ± 81.31 s,
respectively). While this was not statistically significant (neither excluding the upper
equivalence bands nor a zero effect), a mean time change from placebo to caffeine of ~45 s
might be practically meaningful. The standardised effect size for TTF following caffeine
ingestion compared to placebo for the lighter load condition was moderate (d = 0.489
(−0.169 to 1.146)). This effect size is not too dissimilar from those reported in other
meta-analyses though again the interval estimate suggests it may be lower (Grgic et al.,
2019a). Warren et al. (2010) suggested that endurance improvements are the result of
greater muscle fibre recruitment in the caffeine condition. However, the moderate effect
for caffeine in the low load condition (30% MVC) was not evident in the higher load
condition (70% MVC). At heavier loads electromyographic amplitude (a proxy for motor
unit recruitment) is higher than at lighter loads (Fisher, Steele & Smith, 2017). As such,
caffeine might be less likely to positively influence muscular endurance by motor unit
recruitment in a heavier load condition. In contrast, at lighter loads caffeine ingestion
might positively influence motor unit cycling and re-recruitment to sustain the force
requirements, and thus enhance muscular endurance.
In addition, prior research has suggested that caffeine might impact on TTF due to
its effects upon perceived effort and/or perceived pain (Motl, O’Connor & Dishman,
2003; Motl et al., 2006; Astorino et al., 2011; Duncan et al., 2013; De Morree, Klein &
Marcora, 2014; Smirnaul et al., 2017). Previous studies comparing lighter-and heavier-load
exercise to momentary failure have reported similar values for effort, but higher values
for discomfort for a lighter load condition (Fisher & Steele, 2017; Stuart et al., 2018).
Indeed, improvements in measures of relative muscular endurance have been speculated
to be in part due to greater tolerance of perceived discomfort (Fisher et al., 2020).
Thus, any performance enhancement in lighter-compared to heavier-load exercise may be
due to effects upon perceptual variables. As such we measured both RPE and RPD.
RPE and RPD/perceptual responses
Rating of perceived effort and Rating of perceived discomfort were recorded immediately
after completing the knee extension task. There were no significant differences between
caffeine and placebo conditions for RPE which, whilst not maximal in value (e.g. 10) for
all participants, supports that the effort level was likely similar across all conditions.
Indeed, equivalence testing was statistically significant suggesting that the RPEs reported
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were equivalent across conditions and loads. This is somewhat contradictory of previous
research which has reported lower RPE values following caffeine ingestion during exercise,
though concordant with no differences in RPE at or after task failure (Doherty & Smith,
2005). This might be expected given that task failure should theoretically represent a
ceiling for RPE and result in maximal or near maximal values irrespective of performance
(even when affected by supplementation). Indeed, our results supported that RPE was
statistically equivalent at task failure between conditions. Doherty & Smith (2005) however
reported that the reduction in RPE during constant load exercise explained 29% of the
variance in performance. Though a limitation of our study was that we did not measure
RPE during each condition (and thus does not rule out RPE as potentially impacting
TTF), a strength was the consideration of both ratings of perceived effort and discomfort
where previous studies have generally failed to differentiate between the two. Since caffeine
is shown to produce analgesic effects that may improve performance by reducing pain
perception (Motl, O’Connor & Dishman, 2003; Motl et al., 2006; Astorino et al., 2011;
Duncan et al., 2013), our data might simply support that effort was equivalent and
unaffected by conditions independently of pain/discomfort perception.
Analyses of RPD also revealed no significant differences between heavier-or lighter-load
conditions or between placebo or caffeine conditions. This could be interpreted to
suggest that caffeine had no analgesic effects upon the perception of discomfort during
prolonged exercise to momentary failure with a lighter-compared to heavier-load. That
there were no differences between heavier-and lighter-load conditions (irrespective of
caffeine or placebo conditions) suggests that an isometric task performed for time to failure
might differ in the perceived discomfort incurred in comparison to performing traditional
repetitions (e.g. both concentric and eccentric muscle actions). Certainly, previous
research has supported differences in perceived discomfort between heavier-and
lighter-load exercise (Fisher & Steele, 2017; Stuart et al., 2018). Fisher & Steele (2017)
reported RPD values for dynamic knee extension exercise of 8.7 and 6.5 for lighter-load
(50% MVC) and heavier-load (80% MVC), respectively. Stuart et al. (2018) reported
values of 6.3 for heavier-load (80% MVC) and 8.0 and 8.3 for lighter load (50% MVC) for
males and females, respectively. However, perceived discomfort values from the present
study using an isometric task were more similar (CAFF = 8.0 and PLA = 7.2 for 30%
MVC and CAFF = 7.5 and PLA = 7.4 for 70% MVC). Previous literature has reported
significantly greater values for pain and exertion for an isometric task using 50% MVC
compared to a dynamic task using 75% MVC when performed to momentary failure
(Frey Law et al., 2010). This suggests the relationship for discomfort might be different
for isometric compared to dynamic muscle actions. Nonetheless, despite not finding
statistically significant differences for perceived discomfort, we also did not find that RPD
was statistically equivalent in the lighter-load condition whereas it was for the heavier-load
condition. The standardised effect size for comparison of RPD between caffeine and
placebo in the lighter-load condition (d = 0.543 (−0.110 to 1.196)) was not too dissimilar
form the standardised effect size found for TTF (d = 0.489 (−0.169 to 1.146)). But,
contrastingly to the anticipated analgesic effects of caffeine, this suggested that during the
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lighter-load condition participants rated higher perceptions of discomfort as a result of
caffeine supplementation. These, results question whether there may be either an effort
reducing, or an analgesic effect of caffeine that results in improved endurance under
conditions of higher discomfort (i.e. lighter-loads) but this should be examined in further
research.
Limitations
It would be remiss not to discuss the limitations of the present study. Primarily, we did not
include a non-placebo control condition and as such we cannot be certain that a placebo
effect was not evident. In addition, we did not assess the effectiveness of blinding
upon participants who might have experienced typical sensation of increased arousal
following caffeine consumption compared to placebo. Indeed, Saunders et al. (2017)
suggest that supplement identification can influence exercise performance. Furthermore,
we did not measure blood caffeine concentrations and thus the provision of a specific dose
(100 mg) combined with the potentially different absorption rates as a result of oral
contraceptive or genetic factors cannot be discounted. A further limitation is the sample
size in our study; however, we have presented a larger participant number than many
previous studies, and we believe the study design along with the sample size fairly
represents the results obtained. Based on the contemporary thinking surrounding a
gene-caffeine interaction (Guest et al., 2018), as well as the possibility that an oral
contraceptive pill might impact the effects of caffeine upon the body (Abernethy & Todd,
1985), future research might consider genetic testing as well as consideration of the
menstrual cycle and contraceptive use; something which we failed to do. As such a larger
sample size might become redundant in females where assessment of the effects of caffeine
could be measured based on individual variables. Also, we accept that larger caffeine
doses (3–6 mg·kg−1 or larger) might produce more notable positive effects upon strength
(Pickering & Kiely, 2019). However, our aim was not to identify optimal dose or current
best practice, but rather fill a gap within the literature (Spriet, 2014) by considering
whether, and how, low caffeine dosage impacts strength and muscular endurance at
heavier-and lighter-loads. In addition, as noted we did not measure RPE or RPD during
the exercise bouts and thus the lack of effects at task failure may miss any effect on the
exercise bout. Lastly, we did not measure other possible mechanisms through which
the effects of caffeine are thought to impact maximal strength and muscular endurance.
Thus, the effects upon MVC seen here may be due to unmeasured mechanisms such as
blocking the binding of adenosine to A1 and A2a G-protein coupled receptor sites and
increased sarcoplasmic reticulum calcium release impacting upon the central nervous
system and motor unit recruitment respectively (Grgic et al., 2019b).
CONCLUSIONS
In the present study of females, we found a statistically significant effect of low dose
caffeine (100 mg, equating to ~1.50 mg·kg−1) upon knee extension MVC, though the
meaningfulness of this performance enhancement is less clear. Further, we did not find
statistically significant effects of low dose caffeine upon TTF, or RPE and RPD. Indeed,
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RPE was statistically equivalent for isometric knee extension to momentary task failure in
all conditions examined, and RPD for the heavier-load condition. As discussed herein,
the dosage used represents an ecologically valid approach (e.g. a specific absolute dosage
rather than a personalised relative dose per kg of body mass), and further, is representative
of typical caffeinated beverages. Since caffeine consumption can present with some
deleterious side effects and withdrawal symptoms, we suggest a low caffeine dose (similar
to that found in typical caffeinated beverages) might be suitable practical approach to
attain enhancements in muscular strength, though not relative muscular endurance.
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